中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
10期
131-132,133
,共3页
非典型鳞状细胞%TBS%病理诊断%宫颈上皮内瘤变
非典型鱗狀細胞%TBS%病理診斷%宮頸上皮內瘤變
비전형린상세포%TBS%병리진단%궁경상피내류변
The atypical squamous cells%TBS%Pathological diagnosis%Cervical intraepithelial neoplasia
目的：对宫颈细胞学诊断TBS（The Bethesda System for reporting cervical cytology）分类中非典型鳞状上皮细胞（atypical squamous cell，ASC）的结局的分析，提高对TBS分类中ASC诊断的认识，以及ASC及时明确诊断的意义。方法：回顾性分析TCT标本中的1346例有明确病理诊断的ASC患者的临床资料，所有患者均在行阴道镜下多点位宫颈活检病理诊断。结果：1346例ASC患者中，836例为良性反应性改变，占62.10%（836/1346）；247例为CINⅠ级，占18.31%（247/1346）；263例为CINⅡ级以上，占19.53%（263/1346）。结论：对宫颈细胞学TBS分类中ASC的诊断，应提高认识，及时明确诊断，防止漏诊或过度治疗。
目的：對宮頸細胞學診斷TBS（The Bethesda System for reporting cervical cytology）分類中非典型鱗狀上皮細胞（atypical squamous cell，ASC）的結跼的分析，提高對TBS分類中ASC診斷的認識，以及ASC及時明確診斷的意義。方法：迴顧性分析TCT標本中的1346例有明確病理診斷的ASC患者的臨床資料，所有患者均在行陰道鏡下多點位宮頸活檢病理診斷。結果：1346例ASC患者中，836例為良性反應性改變，佔62.10%（836/1346）；247例為CINⅠ級，佔18.31%（247/1346）；263例為CINⅡ級以上，佔19.53%（263/1346）。結論：對宮頸細胞學TBS分類中ASC的診斷，應提高認識，及時明確診斷，防止漏診或過度治療。
목적：대궁경세포학진단TBS（The Bethesda System for reporting cervical cytology）분류중비전형린상상피세포（atypical squamous cell，ASC）적결국적분석，제고대TBS분류중ASC진단적인식，이급ASC급시명학진단적의의。방법：회고성분석TCT표본중적1346례유명학병리진단적ASC환자적림상자료，소유환자균재행음도경하다점위궁경활검병리진단。결과：1346례ASC환자중，836례위량성반응성개변，점62.10%（836/1346）；247례위CINⅠ급，점18.31%（247/1346）；263례위CINⅡ급이상，점19.53%（263/1346）。결론：대궁경세포학TBS분류중ASC적진단，응제고인식，급시명학진단，방지루진혹과도치료。
Objective:To diagnose cervical cytology TBS classification analysis of ASC ending,improve our understanding of ASC in the TBS classification diagnosis,and ASC timely diagnosis significance. Method:TCT specimen of 1346 cases with clear pathological diagnosis of patients with ASC were collect,and were retrospectively analyzed. More than 1346 patients were under colposcope point cervical biopsy pathological diagnosis. Result:1346 patients with ASC,among them,836 cases of benign reactivity change,accounted for 62.10%(836/1346);247 cases of CINⅠlevel,accounting for 18.31%(247/1346);263 cases of CINⅡmagnitude,accounting for 19.53%(263/1346). Conclusion:The diagnosis of cervical cytology TBS classification in ASC,we should raise awareness,and timely diagnosis,preventing misdiagnosis or excessive treatment.
